You are here
- Home
- Therapy Areas
- Cardiovascular
Characterisation of Gastrointestinal Transit of Four New Developed Gel Matrix Tablets With Different Erosion Rates by Means of MMM Measurement Under Fasting and Fed Conditions
- Disease
- method and model studies
- Generic Name
- No Drug
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Oct 12, 2010
- Study Name
- D1840M00017
- Study Id
- D1840M00017
- ClinicalTrials.gov ID
- NCT01224587
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
